Sponsored Article Image

A message from Curtiss-Wright

High-Temperature neutron flux detectors for Generation IV reactors and SMRs

Learn More

Research & Applications

Progress being made toward Mo-99 production at Darlington

September 29, 2020, 12:25PMNuclear News

Darlington nuclear generating station. Photo: OPG

Ontario Power Generation, its subsidiary Laurentis Energy Partners, and BWXT ITG Canada and its affiliates announced on September 24 that the companies are making “significant progress” toward the production of molybdenum-99 at OPG’s Darlington nuclear power plant. Darlington will become the first commercial operating nuclear reactor to produce the medical radioisotope.

A precursor to technetium-99m, Mo-99 is used in more than 40 million procedures a year to detect cancers and diagnose various medical conditions.

To continue reading, log in or create a free account!

Related Articles

Supporting ANS now, for the future

March 18, 2026, 10:03AMNuclear NewsHash Hashemian

From kindergarten classrooms to national security facilities, each event I attended during the opening weeks of the new year underscored one truth: The future of nuclear energy depends on the...

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Saskatchewan expands its nuclear plans

January 30, 2026, 12:21PMNuclear News

This week, the government of Saskatchewan, alongside electric utility SaskPower, announced plans to formally evaluate the deployment of large nuclear technologies. This process will take place...